Loading insider details...
Beta
Latest Form 4 (May 27, 2026): Tax Withholding of 4,036 SGMO shares, $703.47.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 27, 2026 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 4,036 | $703.47 |
| Apr 3, 2026 | SANGAMO THERAPEUTICS, INC (SGMO) | Grant/Award | 800,000 | n/a |
| Feb 27, 2026 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 1,650 | $779.63 |
| Jan 26, 2026 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 36,676 | $14.6K |
| Nov 26, 2025 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 2,035 | $847.78 |
| Oct 24, 2025 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 44,122 | $29.1K |
| Aug 26, 2025 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 1,434 | $840.75 |
| Jul 24, 2025 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 31,866 | $15.3K |
| May 28, 2025 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 1,433 | $678.24 |
| Apr 24, 2025 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 31,866 | $24.7K |